Welcome: Guest | Site Use Options | Register | Login |

I-Cordis LLC

I-Cordis LLC

Profile last edited on: 8/8/2020
4362 West Pine Boulevard
Saint Louis, MO 63108
  (303) 829-8122
Business Identifier: Immunomodulatory molecule to prevent and treat heart failure
Public Profile:
I-Cordis LLC has developed a immunomodulatory molecule to prevent and treat heart failure. The firm was spun out of Washington University research on immunomodulatory molecules that were both known to be safe in humans and proven to have cardioprotective effects in order to identify novel targets and tools to treat heart failure. This research effort led to both the identification of B lymphocytes as an innovative target to modulate the immune response in heart failure and to the identification of Pirfenidone as an ideal starting point to develop a safe and effective drug for this patient population.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Development of a Novel Immunomodulatory Pyridone for the Treatment of Acute Heart Damage

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920